Why do I need cholesterol medicine so young?

Young adults may need cholesterol medication due to genetic conditions like familial hypercholesterolemia, early cardiovascular risk factors, or significantly elevated cholesterol levels that lifestyle changes alone cannot manage. Early intervention with statins or other medications can prevent decades of arterial damage and reduce long-term heart disease risk.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

The Surprising Reality of Early Cholesterol Treatment

Being prescribed cholesterol medication in your 20s, 30s, or early 40s can feel shocking. You might wonder if your doctor is being overly cautious or if something is seriously wrong with your health. The truth is that early intervention for high cholesterol has become increasingly common and evidence-based, particularly as we better understand how cardiovascular disease develops over decades, not years.

The decision to start cholesterol medication at a younger age typically stems from one of several factors: genetic predisposition, accumulated risk factors, or cholesterol levels so elevated that lifestyle modifications alone won't provide adequate protection. Understanding why your doctor recommended medication can help you make an informed decision about your cardiovascular health and long-term wellbeing.

Understanding Your Cholesterol Numbers

Before diving into why you might need medication, it's crucial to understand what your cholesterol numbers actually mean. Total cholesterol includes several components: LDL (low-density lipoprotein) cholesterol, often called 'bad' cholesterol; HDL (high-density lipoprotein) cholesterol, known as 'good' cholesterol; and triglycerides, another type of blood fat. However, modern cardiovascular risk assessment goes beyond these basic measurements.

Cholesterol Target Levels for Young Adults

Target levels may vary based on individual risk factors and should be discussed with your healthcare provider.
BiomarkerOptimalBorderlineHigh Risk
LDL CholesterolLDL Cholesterol<100 mg/dL100-159 mg/dL≥160 mg/dL
ApoBApoB<80 mg/dL80-119 mg/dL≥120 mg/dL
HDL CholesterolHDL Cholesterol>60 mg/dL40-59 mg/dL<40 mg/dL
TriglyceridesTriglycerides<100 mg/dL100-149 mg/dL≥150 mg/dL
Lp(a)Lp(a)<30 mg/dL30-50 mg/dL>50 mg/dL

Target levels may vary based on individual risk factors and should be discussed with your healthcare provider.

Apolipoprotein B (ApoB) has emerged as a more accurate predictor of cardiovascular risk than traditional cholesterol measurements. ApoB represents the total number of atherogenic particles in your blood, providing a clearer picture of your arterial plaque risk. If you're concerned about your cholesterol levels and want comprehensive testing beyond standard panels, at-home testing can provide detailed insights into your cardiovascular markers.

The following table shows optimal, borderline, and high-risk levels for key cholesterol markers in young adults.

Genetic Factors: When Your DNA Drives the Decision

Familial Hypercholesterolemia (FH)

Familial hypercholesterolemia affects approximately 1 in 250 people worldwide, making it one of the most common genetic disorders. If you have FH, your body cannot effectively remove LDL cholesterol from your blood, leading to levels that can be two to three times higher than normal from birth. Without treatment, men with FH have a 50% chance of having a heart attack by age 50, while women face the same risk by age 60.

The diagnosis of FH often comes as a surprise during routine blood work or after a family member experiences an early heart attack. If your LDL cholesterol is above 190 mg/dL without other causes, or above 160 mg/dL with a family history of early heart disease, your doctor will likely screen for FH. Early treatment with statins can normalize life expectancy for people with FH, which is why medication is typically started as soon as the diagnosis is confirmed.

Other Genetic Variations

Beyond FH, numerous genetic variations can affect how your body processes cholesterol. Elevated lipoprotein(a), or Lp(a), is another inherited condition that significantly increases cardiovascular risk. Unlike other cholesterol markers, Lp(a) levels are determined almost entirely by genetics and don't respond well to lifestyle changes. If your Lp(a) is elevated, your doctor may recommend more aggressive LDL lowering to offset this additional risk factor.

Risk Factor Accumulation in Young Adults

Even without genetic conditions, young adults can accumulate enough risk factors to warrant cholesterol medication. The concept of 'risk factor burden' considers not just your cholesterol levels but your overall cardiovascular risk profile. This comprehensive assessment helps determine whether the benefits of medication outweigh any potential risks at your age.

Key risk factors that might prompt early medication include diabetes or prediabetes, hypertension, obesity (particularly abdominal obesity), smoking history, chronic inflammatory conditions, family history of premature heart disease, and certain ethnicities with higher cardiovascular risk. The presence of multiple risk factors creates a multiplicative, not additive, effect on your cardiovascular risk.

The Role of Inflammation and Metabolic Health

High-sensitivity C-reactive protein (hs-CRP) measures inflammation in your body and serves as an independent predictor of cardiovascular events. Young adults with elevated hs-CRP alongside high cholesterol face significantly increased risk, even if other traditional risk factors appear normal. Similarly, insulin resistance and metabolic syndrome can accelerate atherosclerosis development, making earlier intervention necessary.

Regular monitoring of inflammatory markers and metabolic health indicators can help you and your healthcare provider make informed decisions about treatment timing. Understanding your complete metabolic profile, including markers like HbA1c, fasting insulin, and inflammatory markers, provides crucial context for cholesterol management decisions.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

When Lifestyle Changes Aren't Enough

Most doctors prefer to try lifestyle modifications before prescribing medication to young patients. A heart-healthy diet, regular exercise, weight management, and stress reduction can significantly improve cholesterol levels. However, genetics plays a substantial role in determining your cholesterol levels, and some people simply cannot achieve safe levels through lifestyle changes alone.

Studies show that even with optimal lifestyle modifications, most people can only reduce their LDL cholesterol by 20-30%. If your baseline LDL is 190 mg/dL due to genetic factors, the best lifestyle changes might only bring it down to 130-150 mg/dL, still well above the recommended target for someone with additional risk factors. This biological reality, not a failure of willpower, often necessitates medication.

The Time Factor in Cardiovascular Disease

Atherosclerosis develops over decades through a process called 'cholesterol years,' similar to how we measure smoking exposure in 'pack years.' The cumulative exposure to elevated LDL cholesterol determines your lifetime cardiovascular risk. Starting medication earlier means preventing years or decades of arterial damage, which cannot be fully reversed once established.

Research from the field of preventive cardiology shows that maintaining lower LDL levels from a younger age provides greater benefit than achieving the same levels later in life. This concept of 'primordial prevention' focuses on preventing risk factors from developing rather than treating them after they appear.

Types of Cholesterol Medications for Young Adults

Statins remain the first-line treatment for high cholesterol in young adults due to their extensive safety record and proven cardiovascular benefits. Modern statins like rosuvastatin and atorvastatin are highly effective and generally well-tolerated. Despite concerns about side effects, large studies show that true statin intolerance affects only 5-10% of patients, and many reported side effects occur at similar rates with placebo.

For those who cannot tolerate statins or need additional LDL lowering, several alternatives exist. Ezetimibe blocks cholesterol absorption in the intestines and can be used alone or with statins. PCSK9 inhibitors, though more expensive, provide powerful LDL reduction through injectable medications given every two to four weeks. Bempedoic acid offers another oral option for those with statin intolerance. The choice of medication depends on your specific situation, including your LDL target, other health conditions, and insurance coverage.

Addressing Common Concerns About Early Treatment

Long-term Safety

One of the biggest concerns young adults have about cholesterol medication is taking it for potentially 40-50 years. Fortunately, statins have been used since the 1980s, providing decades of safety data. Long-term studies show that statins remain safe and effective even with extended use, and the cardiovascular benefits far outweigh any risks for appropriately selected patients.

Regular monitoring through blood tests can catch any potential issues early. Most doctors recommend checking liver enzymes and creatine kinase when starting medication, then periodically thereafter. Some patients may need additional monitoring for blood sugar changes, as statins can slightly increase diabetes risk in predisposed individuals.

Impact on Lifestyle and Fertility

Many young adults worry that taking cholesterol medication means they've failed at healthy living or that it will limit their activities. In reality, medication works alongside, not instead of, healthy lifestyle choices. You should continue exercising, eating well, and maintaining a healthy weight, as these habits provide benefits beyond cholesterol management.

For women of childbearing age, cholesterol medication requires special consideration. Statins and other cholesterol medications are contraindicated during pregnancy and breastfeeding. Women who might become pregnant need to use reliable contraception and should discuss family planning with their healthcare provider. Some women may temporarily discontinue medication during pregnancy attempts and pregnancy, though this decision requires careful risk-benefit analysis.

Making an Informed Decision

The decision to start cholesterol medication at a young age should involve a thorough discussion with your healthcare provider about your individual risk factors, family history, lifestyle factors, and personal preferences. Consider seeking a second opinion if you're unsure, particularly from a preventive cardiologist who specializes in early intervention strategies.

Ask your doctor about your 10-year and lifetime cardiovascular risk scores, which can help quantify the potential benefits of treatment. Discuss specific LDL targets based on your risk profile and understand how medication fits into your overall prevention strategy. Remember that starting medication doesn't mean you'll necessarily take it forever; risk factors can change, and new treatments may become available.

For those interested in taking a more proactive approach to their cardiovascular health, comprehensive biomarker testing can provide valuable insights beyond standard cholesterol panels. Advanced testing can reveal additional risk factors and help track your response to treatment over time. Consider uploading your existing lab results to SiPhox Health's free analysis service for personalized insights and recommendations based on your unique health profile.

The Path Forward: Embracing Prevention

Being prescribed cholesterol medication at a young age might feel like a setback, but it's actually an opportunity. Early identification and treatment of cardiovascular risk factors can prevent heart attacks, strokes, and other complications that might otherwise occur in middle age. You're not too young to need medication; you're young enough to prevent decades of arterial damage.

The future of cardiovascular prevention continues to evolve, with new medications, genetic testing, and personalized risk assessment tools becoming available. By taking action now, you're positioning yourself to benefit from these advances while protecting your heart health for decades to come. Remember that managing cholesterol is just one aspect of cardiovascular health. Continue focusing on all modifiable risk factors, stay informed about your health metrics, and maintain open communication with your healthcare team.

References

  1. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143.[PubMed][DOI]
  2. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population. European Heart Journal. 2013;34(45):3478-3490.[PubMed][DOI]
  3. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal. 2017;38(32):2459-2472.[PubMed][DOI]
  4. Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532-2561.[PubMed][DOI]
  5. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2020;41(1):111-188.[PubMed][DOI]
  6. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology. 2019;4(12):1287-1295.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol at home?

You can test your cholesterol at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes comprehensive cholesterol testing including ApoB, LDL, HDL, and triglycerides, providing lab-quality results from the comfort of your home.

What age is considered 'young' for cholesterol medication?

Generally, needing cholesterol medication before age 45-50 is considered young. However, people with familial hypercholesterolemia may start statins in their teens or twenties, while those with multiple risk factors might begin treatment in their thirties.

Can I stop taking cholesterol medication if my levels improve?

This depends on why you started medication. If you have a genetic condition like familial hypercholesterolemia, you'll likely need lifelong treatment. However, if medication was started due to lifestyle factors that you've successfully modified, your doctor might consider a trial off medication with close monitoring.

Do statins cause muscle pain and weakness?

While muscle symptoms are commonly reported, true statin-induced myopathy affects only 1-5% of patients. Many reported symptoms occur at similar rates with placebo. If you experience muscle issues, your doctor can try a different statin, adjust the dose, or consider alternative medications.

Will cholesterol medication affect my athletic performance?

Most people can maintain or even improve their athletic performance while taking cholesterol medication. Some elite athletes take statins without issues. If you experience fatigue or muscle problems, work with your doctor to find the right medication and dose that doesn't impact your activities.

Should I get genetic testing for cholesterol conditions?

If your LDL cholesterol is very high (>190 mg/dL) or you have a strong family history of early heart disease, genetic testing for familial hypercholesterolemia might be recommended. This can help guide treatment decisions and prompt family member screening.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details